Investigating peptide sequence variations for 'double-click' stapled p53 peptides.

Stapling peptides for inhibiting the p53/MDM2 interaction is a promising strategy for developing anti-cancer therapeutic leads. We evaluate double-click stapled peptides formed from p53-based diazidopeptides with different staple positions and azido amino acid side-chain lengths, determining the impact of these variations on MDM2 binding and cellular activity. We also demonstrate a K24R mutation, necessary for cellular activity in hydrocarbon-stapled p53 peptides, is not required for analogous 'double-click' peptides.

[1]  D. Spring,et al.  Functionalised staple linkages for modulating the cellular activity of stapled peptides , 2014 .

[2]  Evripidis Gavathiotis,et al.  Distinct BimBH3 (BimSAHB) stapled peptides for structural and cellular studies. , 2014, ACS chemical biology.

[3]  Philipp M. Cromm,et al.  Direct targeting of Rab-GTPase-effector interactions. , 2014, Angewandte Chemie.

[4]  L. Walensky,et al.  Hydrocarbon-Stapled Peptides: Principles, Practice, and Progress , 2014, Journal of medicinal chemistry.

[5]  Brian J. Smith,et al.  Further insights into the effects of pre-organizing the BimBH3 helix. , 2014, ACS chemical biology.

[6]  W. S. Horne,et al.  Dynamic covalent side‐chain cross‐links via intermolecular oxime or hydrazone formation from bifunctional peptides and simple organic linkers , 2014, Journal of peptide science : an official publication of the European Peptide Society.

[7]  Alexander M. Spokoyny,et al.  Convergent diversity-oriented side-chain macrocyclization scan for unprotected polypeptides. , 2013, Organic & biomolecular chemistry.

[8]  L. Vassilev,et al.  Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy , 2013, Proceedings of the National Academy of Sciences.

[9]  Alexander M. Spokoyny,et al.  A perfluoroaryl-cysteine S(N)Ar chemistry approach to unprotected peptide stapling. , 2013, Journal of the American Chemical Society.

[10]  H. Murakami,et al.  In vitro selection of multiple libraries created by genetic code reprogramming to discover macrocyclic peptides that antagonize VEGFR2 activity in living cells. , 2013, ACS chemical biology.

[11]  Andrew J. Wilson,et al.  Inhibition of α-helix-mediated protein-protein interactions using designed molecules. , 2013, Nature chemistry.

[12]  Brian J. Smith,et al.  Stabilizing the pro-apoptotic BimBH3 helix (BimSAHB) does not necessarily enhance affinity or biological activity. , 2013, ACS chemical biology.

[13]  Rudi Fasan,et al.  Macrocyclization of Organo‐Peptide Hybrids through a Dual Bio‐orthogonal Ligation: Insights from Structure–Reactivity Studies , 2013, Chembiochem : a European journal of chemical biology.

[14]  Xiaozhen Hu,et al.  Development of α-helical calpain probes by mimicking a natural protein-protein interaction. , 2012, Journal of the American Chemical Society.

[15]  Shaomeng Wang,et al.  Design of triazole-stapled BCL9 α-helical peptides to target the β-catenin/B-cell CLL/lymphoma 9 (BCL9) protein-protein interaction. , 2012, Journal of medicinal chemistry.

[16]  Peter S. Kutchukian,et al.  Structure of the stapled p53 peptide bound to Mdm2. , 2012, Journal of the American Chemical Society.

[17]  Jiandong Chen,et al.  Conjugation of spermine enhances cellular uptake of the stapled peptide-based inhibitors of p53-Mdm2 interaction. , 2011, Bioorganic & medicinal chemistry letters.

[18]  Jiandong Chen,et al.  Achieving cell penetration with distance-matching cysteine cross-linkers: a facile route to cell-permeable peptide dual inhibitors of Mdm2/Mdmx. , 2011, Chemical communications.

[19]  Robert B. Moore,et al.  Design and structure of stapled peptides binding to estrogen receptors. , 2011, Journal of the American Chemical Society.

[20]  Michael M. Madden,et al.  Synthesis of cell-permeable stapled peptide dual inhibitors of the p53-Mdm2/Mdmx interactions via photoinduced cycloaddition. , 2011, Bioorganic & medicinal chemistry letters.

[21]  D. Lane,et al.  Stapled peptides in the p53 pathway: Computer simulations reveal novel interactions of the staples with the target protein , 2010, Cell cycle.

[22]  Emiko Fire,et al.  The MCL-1 BH3 Helix is an Exclusive MCL-1 inhibitor and Apoptosis Sensitizer , 2010, Nature chemical biology.

[23]  D. Fairlie,et al.  Downsizing human, bacterial, and viral proteins to short water-stable alpha helices that maintain biological potency , 2010, Proceedings of the National Academy of Sciences.

[24]  Alan R. Fersht,et al.  Awakening guardian angels: drugging the p53 pathway , 2009, Nature Reviews Cancer.

[25]  Raymond E. Moellering,et al.  Direct inhibition of the NOTCH transcription factor complex , 2009, Nature.

[26]  Michael M. Madden,et al.  Facile synthesis of stapled, structurally reinforced peptide helices via a photoinduced intramolecular 1,3-dipolar cycloaddition reaction. , 2009, Chemical communications.

[27]  Elizabeth A. Harker,et al.  Cell‐Permeable β‐Peptide Inhibitors of p53/hDM2 Complexation , 2009, Chembiochem : a European journal of chemical biology.

[28]  E. J. Loveridge,et al.  Photocontrollable Peptide‐Based Switches Target the Anti‐Apoptotic Protein Bcl‐xL , 2008, Chembiochem : a European journal of chemical biology.

[29]  Krishna Kumar,et al.  Peptide Tertiary Structure Nucleation by Side‐Chain Crosslinking with Metal Complexation and Double “Click” Cycloaddition , 2008, Chembiochem : a European journal of chemical biology.

[30]  K. Fujimoto,et al.  Development of a series of cross-linking agents that effectively stabilize alpha-helical structures in various short peptides. , 2008, Chemistry.

[31]  Christopher L. McClendon,et al.  Reaching for high-hanging fruit in drug discovery at protein–protein interfaces , 2007, Nature.

[32]  S. Korsmeyer,et al.  Reactivation of the p53 Tumor Suppressor Pathway by a Stapled p53 Peptide , 2007 .

[33]  Neal J. Zondlo,et al.  Determinants of specificity of MDM2 for the activation domains of p53 and p65: proline27 disrupts the MDM2-binding motif of p53. , 2006, Biochemistry.

[34]  Peter Timmerman,et al.  Rapid and Quantitative Cyclization of Multiple Peptide Loops onto Synthetic Scaffolds for Structural Mimicry of Protein Surfaces , 2005, Chembiochem : a European journal of chemical biology.

[35]  S. Korsmeyer,et al.  Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix , 2004, Science.

[36]  L. Vassilev,et al.  In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.

[37]  Yong Wang,et al.  Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor–coactivator interactions , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[39]  Luke G Green,et al.  A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. , 2002, Angewandte Chemie.

[40]  Morten Meldal,et al.  Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. , 2002, The Journal of organic chemistry.

[41]  G. Verdine,et al.  An All-Hydrocarbon Cross-Linking System for Enhancing the Helicity and Metabolic Stability of Peptides , 2000 .

[42]  O. Smart,et al.  Photo-control of helix content in a short peptide. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Helen E Blackwell,et al.  Highly Efficient Synthesis of Covalently Cross-Linked Peptide Helices by Ring-Closing Metathesis. , 1998, Angewandte Chemie.

[44]  D. Lane,et al.  Reactivation of p53: from peptides to small molecules. , 2011, Trends in pharmacological sciences.

[45]  S. Gellman,et al.  Targeting protein-protein interactions: lessons from p53/MDM2. , 2007, Biopolymers.